Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artrya Limited ( (AU:AYA) ) has shared an update.
Artrya Limited has disclosed a change in director Bernie Ridgeway’s interests following the exercise of options. Through Wear Services Pty Ltd, Ridgeway converted 500,000 options at an exercise price of $1.00 each into ordinary shares, representing a $500,000 outlay.
Following the transaction, Ridgeway’s indirect holding via Wear Services increased to 1,651,833 shares, while 1,500,000 options remain exercisable at $1.00 on or before 9 July 2026. The move signals continued financial commitment by the director and modestly increases insider equity alignment with shareholders.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$6.27 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited is an ASX-listed company operating in the medical technology sector. It focuses on developing and commercialising advanced imaging and diagnostic solutions, with a particular emphasis on cardiovascular disease detection and analysis for healthcare providers and patients.
Average Trading Volume: 511,635
Technical Sentiment Signal: Buy
Current Market Cap: A$621.3M
Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.

